Clinical Trial

Semaglutide (Wegovy) Treatment for Trichotillomania

Name: Semaglutide (Wegovy) Treatment for Trichotillomania — clinical trial record (NCT07282769)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2025-12-05; most recent amendment 2026-06-08.

Trial Details

NCT Number	NCT07282769
Lead Sponsor	University of Chicago
Conditions	Trichotillomania (Hair-Pulling Disorder), Trichotillomania, Hair Pulling Disorder, Hair Pulling, Hair-Pulling Disorder
Enrollment	10 participants
Start Date	2026-06
Primary Completion	2027-02 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2026-06-10